In just over two years, pharmaceutical manufacturers must meet the Nov. 27, 2017, deadline of the Drug Supply Chain Security Act (DSCSA), which requires unique product identifiers on certain prescription drug packages. This measure is part of 2013’s Title II of the Drug Quality and Security Act (DQSA), a 10-year rollout of steps to prevent the counterfeiting of drugs distributed in the United States. To help pharmaceutical manufacturers comply with this and other regulations, Pharma EXPO 2015 (Sept. 28–30; Las Vegas Convention Center) will provide access to advanced solutions for the entire pharmaceutical lifecycle and a wide range of educational opportunities.
Co-produced by PMMI, The Association for Packaging and Processing Technologies, and the International Society for Pharmaceutical Engineering (ISPE), and co-located with PMMI’s PACK EXPO Las Vegas, Pharma EXPO will provide a forum where manufacturers in the pharmaceutical, nutraceutical, biopharmaceutical and medical device sectors can learn about the latest regulations, offering clarification as well as actionable insights and sophisticated technologies. Projections indicate the combined event will attract 30,000 attendees to see solutions presented by 2,000 suppliers.